Why Intuitive Surgical Stock Surged 20% in July

What happened

Shares of Intuitive Surgical (NASDAQ: ISRG) climbed 20.3% last month, according to data provided by S&P Global Market Intelligence. The maker of advanced surgical systems is dominating the robotic healthcare industry, as its competitors struggle to enter the market.

So what

Intuitive Surgical got a boost in mid-July when Johnson & Johnson (NYSE: JNJ) said its robotic surgery program was experiencing delays. With J&J now expecting to begin human trials no sooner than the second half of 2022, Intuitive Surgical will have significantly more time before it'll see increased competition. J&J also said it expects to face a more stringent standard for regulatory approval, which could make it more difficult for the healthcare giant to bring its new robotic devices to market.  Intuitive Surgical's da Vinci Xi system.

Intuitive Surgical is the undisputed leader in robotic surgery. Image source: Intuitive Surgical.

Wall Street viewed the news as a signal of increasing barriers to entry for Intuitive Surgical's would-be rivals. In turn, several analysts boosted their price targets for the robotic surgery leader's shares. 

Later in July, Intuitive Surgical went on to deliver better-than-expected second-quarter results, which resulted in even more analyst upgrades. 

Now what 

Due to both the technological superiority of its devices and the ongoing struggles of its rivals, Intuitive Surgical is entrenched as the global leader in robotic surgical systems. With its robot-assisted solutions seeing increased adoption in an expanding array of healthcare segments, Intuitive Surgical is well-positioned to deliver even more gains to investors in the years ahead.

10 stocks we like better than Intuitive Surgical
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Intuitive Surgical wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks


*Stock Advisor returns as of June 2, 2020


Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Intuitive Surgical. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2022 $580 calls on Intuitive Surgical and short January 2022 $600 calls on Intuitive Surgical. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More